Brown MP - Search Results

1

Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5.

Sexl V, Piekorz R, Moriggl R, Rohrer J, Brown MP, Bunting KD, Rothammer K, Roussel MF, Ihle JN. Sexl V, et al. Among authors: brown mp. Blood. 2000 Sep 15;96(6):2277-83. Blood. 2000. PMID: 10979977 Free article.

2

Reconstitution of early lymphoid proliferation and immune function in Jak3-deficient mice by interleukin-3.

Brown MP, Nosaka T, Tripp RA, Brooks J, van Deursen JM, Brenner MK, Doherty PC, Ihle JN. Brown MP, et al. Blood. 1999 Sep 15;94(6):1906-14. Blood. 1999. PMID: 10477719 Free article.

3

CD40 ligand induces an antileukemia immune response in vivo.

Dilloo D, Brown M, Roskrow M, Zhong W, Holladay M, Holden W, Brenner M. Dilloo D, et al. Blood. 1997 Sep 1;90(5):1927-33. Blood. 1997. PMID: 9292526 Free article.

4

IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma.

Bowman L, Grossmann M, Rill D, Brown M, Zhong WY, Alexander B, Leimig T, Coustan-Smith E, Campana D, Jenkins J, Woods D, Kitchingman G, Vanin E, Brenner M. Bowman L, et al. Blood. 1998 Sep 15;92(6):1941-9. Blood. 1998. PMID: 9731051 Free article.

5

Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome.

Pui CH, Ip SH, Thompson E, Dodge RK, Brown M, Wilimas J, Carrabis S, Kung P, Berard CW, Crist WM. Pui CH, et al. Blood. 1989 Jan;73(1):209-13. Blood. 1989. PMID: 2521294 Free article.

6

Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients.

Pui CH, Ip SH, Dodge RK, Carrabis S, Brown M, Crist WM, Berard CW, Kung P, Dahl GV, Murphy SB. Pui CH, et al. Blood. 1988 Sep;72(3):1015-21. Blood. 1988. PMID: 2970871 Free article.

7

Cytokines, Jaks, Stats, health and disease.

Brown MP. Brown MP. Aust N Z J Med. 1999 Feb;29(1):73-8. doi: 10.1111/j.1445-5994.1999.tb01591.x. Aust N Z J Med. 1999. PMID: 10200816 Review. No abstract available.

8

Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma.

Bowman LC, Grossmann M, Rill D, Brown M, Zhong WY, Alexander B, Leimig T, Coustan-Smith E, Campana D, Jenkins J, Woods D, Brenner M. Bowman LC, et al. Hum Gene Ther. 1998 Jun 10;9(9):1303-11. doi: 10.1089/hum.1998.9.9-1303. Hum Gene Ther. 1998. PMID: 9650615

9

Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice.

Brown MP, Topham DJ, Sangster MY, Zhao J, Flynn KJ, Surman SL, Woodland DL, Doherty PC, Farr AG, Pattengale PK, Brenner MK. Brown MP, et al. Nat Med. 1998 Nov;4(11):1253-60. doi: 10.1038/3233. Nat Med. 1998. PMID: 9809548

10

Antitumor responses induced by transgenic expression of CD40 ligand.

Grossmann ME, Brown MP, Brenner MK. Grossmann ME, et al. Among authors: brown mp. Hum Gene Ther. 1997 Nov 1;8(16):1935-43. doi: 10.1089/hum.1997.8.16-1935. Hum Gene Ther. 1997. PMID: 9382959

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters